Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Short-Term Debt issuances (2020 - 2022)

Roivant Sciences' Short-Term Debt issuances history spans 3 years, with the latest figure at $159.9 million for Q4 2022.

  • For Q4 2022, Short-Term Debt issuances rose 339.28% year-over-year to $159.9 million; the TTM value through Dec 2023 reached $159.9 million, down 55.11%, while the annual FY2023 figure was $159.9 million, 339.28% up from the prior year.
  • Short-Term Debt issuances reached $159.9 million in Q4 2022 per ROIV's latest filing, roughly flat from $159.9 million in the prior quarter.
  • In the past five years, Short-Term Debt issuances ranged from a high of $159.9 million in Q2 2022 to a low of -$36.4 million in Q4 2020.
  • Average Short-Term Debt issuances over 3 years is $71.2 million, with a median of $36.4 million recorded in 2021.
  • Peak YoY movement for Short-Term Debt issuances: soared 200.0% in 2021, then skyrocketed 339.28% in 2022.
  • A 3-year view of Short-Term Debt issuances shows it stood at -$36.4 million in 2020, then skyrocketed by 200.0% to $36.4 million in 2021, then skyrocketed by 339.28% to $159.9 million in 2022.
  • Per Business Quant, the three most recent readings for ROIV's Short-Term Debt issuances are $159.9 million (Q4 2022), $159.9 million (Q2 2022), and $36.4 million (Q4 2021).